Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression

Molecular Cancer Therapeutics
Li WanZhao-xia Wang

Abstract

Long noncoding RNAs (lncRNA) are a novel class of transcripts with no protein coding capacity, but with diverse functions in cancer cell proliferation, apoptosis, and metastasis. The lncRNA PVT1 is 1,716 nt in length and located in the chr8q24.21 region, which also contains the myelocytomatosis (MYC) oncogene. Previous studies demonstrated that MYC promotes PVT1 expression in primary human cancers. However, the expression pattern and potential biologic function of PVT1 in non-small cell lung cancer (NSCLC) is still unclear. Here, we found that PVT1 was upregulated in 105 human NSCLC tissues compared with normal samples. High expression of PVT1 was associated with a higher tumor-node-metastasis stage and tumor size, as well as poorer overall survival. Functional analysis revealed that knockdown of PVT1 inhibited NSCLC cell proliferation and induced apoptosis both in vitro and in vivo RNA immunoprecipitation and chromatin immunoprecipitation assays demonstrated that PVT1 recruits EZH2 to the large tumor suppressor kinase 2 (LATS2) promoter and represses LATS2 transcription. Furthermore, ectopic expression of LATS2 increased apoptosis and repressed lung adenocarcinoma cell proliferation by regulating the Mdm2-p53 pathway. Taken to...Continue Reading

References

Mar 5, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yuri TakahashiShinzaburo Noguchi
Aug 24, 2007·The Lancet Oncology·Arduino VerdecchiaUNKNOWN EUROCARE-4 Working Group
Nov 15, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Mojca StrazisarDamjan Glavac
Feb 26, 2009·Cell·Chris P PontingWolf Reik
Jul 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ahmad M KhalilJohn L Rinn
Aug 31, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Tzu-Pin LuEric Y Chuang
Sep 30, 2010·International Journal of Cancer. Journal International Du Cancer·Abel Sanchez-PalenciaM Esther Fárez-Vidal
Jan 20, 2011·Cancer Research·Hideki MurakamiYoshitaka Sekido
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Apr 19, 2011·Cell·Takashi Nagano, Peter Fraser
Dec 24, 2011·BMC Bioinformatics·Usha K MuppiralaDrena Dobbs
Feb 24, 2012·International Journal of Clinical Oncology·Kyoichi KairaNobuyuki Yamamoto
Sep 8, 2012·Nature·Sarah DjebaliThomas R Gingeras
Sep 8, 2012·Genome Research·Jennifer HarrowTim J Hubbard
Mar 1, 2010·Oncology Letters·Hidefumi SasakiYoshitaka Fujii
Nov 1, 2012·Cell Cycle·Ling FangBurton B Yang
May 24, 2013·Science Translational Medicine·Sophie RousseauxSaadi Khochbin
Apr 17, 2014·Biochemical and Biophysical Research Communications·Ying Xia, Yan Gao
Jul 21, 2014·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Rajeev VikramKhaja Shameem Mohammed Abdul
Jul 22, 2014·Nature·Yuen-Yi TsengAnindya Bagchi
Jul 22, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fang WangShu-Han Sun
Aug 26, 2014·Journal of Molecular and Cellular Cardiology·Samir OunzainThierry Pedrazzini
Sep 3, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Shujun FengJianhua Zheng
Nov 14, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Feng YaoWentao Fang

❮ Previous
Next ❯

Citations

Jul 16, 2016·Cell Cycle·Yael Aylon, Moshe Oren
Sep 30, 2016·Journal of Hematology & Oncology·Xinyu TianShengjun Wang
Sep 30, 2016·Cell Death & Disease·Zuozhang YangYa Zhang
Nov 1, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yaqiang Wei, Xiaofei Zhang
Jan 26, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Tao HuangBin Wang
Jan 4, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Pei MaLiang Han
May 8, 2018·Cancers·Federica Lo SardoGiovanni Blandino
May 16, 2018·Journal of Cellular and Molecular Medicine·Defeng LiYuqiang Nie
Aug 12, 2017·Cancer Biomarkers : Section a of Disease Markers·Xun GouZhengrong Wang
Oct 17, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Wanjun YuJipeng Li
Jun 12, 2018·The International Journal of Biological Markers·Heng FanXue-Qing Yao
Nov 8, 2018·Endocrine-related Cancer·Xiang ZhangYupei Zhao
Apr 28, 2019·Bioscience Reports·Zheng WangDaorong Wang
Jun 24, 2017·Cell Death and Differentiation·Noa Furth, Yael Aylon
Jul 13, 2019·Journal of Cellular Physiology·Soudeh Ghafouri-FardMohammad Taheri
Dec 22, 2016·Experimental Hematology & Oncology·Shuyong Wei, Kankan Wang
Feb 12, 2017·Oncology Reports·Zhijie XuZhicheng Gong
Jan 21, 2020·Journal of Cellular Physiology·Zilong YouDa Pang
Oct 8, 2016·Oncotarget·Qin-Nan ChenMing Sun
Nov 20, 2016·Toxicological Sciences : an Official Journal of the Society of Toxicology·Joseph L Dempsey, Julia Yue Cui
Mar 8, 2017·BioMed Research International·Xiangjun ChenHao Dong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.